menu search

Vaxcyte Announces Pricing of $500 Million Public Offering

Vaxcyte Announces Pricing of $500 Million Public Offering
SAN CARLOS, Calif., April 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the pricing of an underwritten public offering of common stock and pre-funded warrants. Vaxcyte is selling 11,200,000 shares of common stock and pre-funded […] The post Vaxcyte Announces Pricing of $500 Million Public Offering appeared first on ForexTV... Read More
Posted: Apr 19 2023, 04:26
Author Name: forextv
Views: 103039

Search within

Pages Search Results: